Cyprus vs Georgia: Share of E. coli infections resistant to cephalosporins
Cyprus
40.5%
in 2022
Georgia
46.5%
in 2022
Cyprus rank
20th
Georgia rank
18th
Share of E. coli infections resistant to cephalosporins over time
- Cyprus
- Georgia
How they compare
Georgia currently reports 46.5% against 40.5% in Cyprus, a difference of 6.0%.
That makes Georgia's figure about 1.1 times Cyprus's.
The two have swapped places 2 times across 6 shared years of data; in 2017 it was Georgia ahead.
Cyprus ranks 20th and Georgia ranks 18th of 46 countries.
Across the 2 decades both report, Cyprus averaged higher in 1 and Georgia in 1.
Head to head by decade
| Decade | Cyprus | Georgia | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 29.2% | 53.1% | 24.0% | Georgia |
| 2020s | 44.4% | 41.8% | 2.6% | Cyprus |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher share of e. coli infections resistant to cephalosporins, Cyprus or Georgia?
- Georgia, at 46.5% against 40.5% in Cyprus as of 2022.
- What is the difference in share of e. coli infections resistant to cephalosporins between Cyprus and Georgia?
- 6.0%, with Georgia ahead.
- How many years of comparable data are there for Cyprus and Georgia?
- 6 years are reported by both, from 2017 to 2022.
- How do Cyprus and Georgia rank globally for share of e. coli infections resistant to cephalosporins?
- Cyprus ranks 20th and Georgia ranks 18th of 46 countries.
- Where does this data come from?
- World Health Organization – processed by Our World in Data, published as Share of E. coli infections resistant to cephalosporins. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested (%).